Justin Taylor

12.6k total citations · 1 hit paper
79 papers, 1.7k citations indexed

About

Justin Taylor is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Justin Taylor has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 31 papers in Molecular Biology and 21 papers in Genetics. Recurrent topics in Justin Taylor's work include Acute Myeloid Leukemia Research (31 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lymphoma Diagnosis and Treatment (10 papers). Justin Taylor is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lymphoma Diagnosis and Treatment (10 papers). Justin Taylor collaborates with scholars based in United States, United Kingdom and China. Justin Taylor's co-authors include Omar Abdel‐Wahab, Wenbin Xiao, Mikkael A. Sekeres, Lemuel Clark Velasco, James Chung Hang Chow, Cameron Smith, Loretta S. Davis, Dan K. Chalker, Arnon Krongrad and E. C. C. Lin and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Justin Taylor

73 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1996 605 citations Lemuel Clark Velasco, Dan K. Chalker et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Justin Taylor United States	18	708	485	362	276	184	79	1.7k
Aleksandar Dimovski North Macedonia	23	602 0.9×	139 0.3×	594 1.6×	151 0.5×	778 4.2×	134	1.9k
Geoffrey M. Matthews Australia	23	863 1.2×	178 0.4×	251 0.7×	254 0.9×	58 0.3×	42	1.8k
K Houglum United States	18	437 0.6×	338 0.7×	189 0.5×	111 0.4×	114 0.6×	22	2.2k
Khalid Amin United States	21	767 1.1×	88 0.2×	504 1.4×	419 1.5×	120 0.7×	115	2.2k
Li‐Yu Tsai Taiwan	22	574 0.8×	186 0.4×	61 0.2×	221 0.8×	47 0.3×	67	1.7k
Pirjo Koistinen Finland	19	619 0.9×	114 0.2×	246 0.7×	204 0.7×	120 0.7×	52	1.2k
Jiayu Wei China	8	1.1k 1.5×	321 0.7×	116 0.3×	283 1.0×	35 0.2×	19	2.2k
Bin Yang China	26	542 0.8×	89 0.2×	187 0.5×	79 0.3×	56 0.3×	109	1.9k
Osamu Midorikawa Japan	22	525 0.7×	325 0.7×	178 0.5×	136 0.5×	72 0.4×	52	1.4k
Órla P. Barry Ireland	14	965 1.4×	93 0.2×	437 1.2×	191 0.7×	72 0.4×	21	1.9k

Countries citing papers authored by Justin Taylor

Since Specialization

Citations

This map shows the geographic impact of Justin Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Taylor more than expected).

Fields of papers citing papers by Justin Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Taylor. The network helps show where Justin Taylor may publish in the future.

Co-authorship network of co-authors of Justin Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Taylor. A scholar is included among the top collaborators of Justin Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Taylor. Justin Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaoqiong, et al.. (2025). Intercurrent presentation of hairy cell leukemia and diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis: a case report. Leukemia Research Reports. 24. 100535–100535.

Wheeler, Emily C., Benjamín Martín, Melanie Donahue, et al.. (2024). Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML. Science Translational Medicine. 16(728). eade2774–eade2774. 17 indexed citations

Malig, Maika, Olga Sala‐Torra, Mary Wood, et al.. (2024). Genomic Proximity Mapping (GPM): Evaluation of a Next Generation Cytogenomic Assay for Improved Risk Stratification in Acute Myeloid Leukemia. Blood. 144(Supplement 1). 6157–6157. 1 indexed citations

Abdel‐Wahab, Omar, et al.. (2024). New Means and Challenges in the Targeting of BTK. Clinical Cancer Research. 30(11). 2333–2341. 11 indexed citations

Sekeres, Mikkael A., Hetty E. Carraway, Richard M. Stone, et al.. (2024). A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-Risk, Non-Del(5q) Patients with Myelodysplastic Syndromes: Phase Ib Results. Blood. 144(Supplement 1). 1821–1821. 1 indexed citations

Taylor, Justin, et al.. (2024). Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies. Cells. 13(16). 1392–1392. 4 indexed citations

Taylor, Justin, et al.. (2024). BTK inhibitors: past, present, and future. Trends in Pharmacological Sciences. 45(8). 691–707. 17 indexed citations

Stanchina, Michele, Alexey V. Danilov, Jorge J. Castillo, et al.. (2024). Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia. Nature Reviews Clinical Oncology. 21(12). 867–887. 7 indexed citations

Bewersdorf, Jan Philipp, Maximilian Stahl, Justin Taylor, et al.. (2023). E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial. Leukemia. 37(12). 2512–2516. 36 indexed citations

10.

Totiger, Tulasigeri M., et al.. (2023). Targeted Therapy Development in Acute Myeloid Leukemia. Biomedicines. 11(2). 641–641. 30 indexed citations

11.

Beckedorff, Felipe, Tulasigeri M. Totiger, Maurizio Affer, et al.. (2023). Altered RNA Export in SF3B1 Mutants Increases Sensitivity to Nuclear Export Inhibition. Blood. 142(Supplement 1). 44–44. 1 indexed citations

12.

Totiger, Tulasigeri M., et al.. (2023). The LSD1 Inhibitor Ory-1001 (ladademstat) in Combination with Menin Inhibitor SNDX-5613 (revumenib) Has Synergistic in Vitro Activity in KMT2A-Rearranged AML Models. Blood. 142(Supplement 1). 5691–5691. 1 indexed citations

13.

Affer, Maurizio, et al.. (2023). Preparation of Cytoplasmic and Nuclear Long RNAs from Primary and Cultured Cells. Journal of Visualized Experiments. 1 indexed citations

14.

Taylor, Justin, et al.. (2023). Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL). Genes. 14(12). 2182–2182. 17 indexed citations

15.

Batta, Kiran, Naveen Pemmaraju, Deepti P. Wilks, et al.. (2021). Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin. Leukemia. 35(11). 3299–3303. 18 indexed citations

16.

Moy, Andrea P., Stephen W. Dusza, Jae H. Park, et al.. (2021). Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos)–associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients. Journal of the American Academy of Dermatology. 86(1). 232–234. 4 indexed citations

17.

Pangallo, Joseph, Jean‐Jacques Kiladjian, Bruno Cassinat, et al.. (2020). Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood. 135(13). 1032–1043. 11 indexed citations

18.

Taylor, Justin, Xiaoli Mi, Khrystyna North, et al.. (2020). Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 136(13). 1477–1486. 38 indexed citations

19.

Taylor, Justin, et al.. (2009). Acquired left ventricular outflow tract obstruction and cardiogenic shock treated with β-blockers. The American Journal of Emergency Medicine. 27(3). 373.e1–373.e3. 3 indexed citations

20.

Velasco, Lemuel Clark, Dan K. Chalker, James Chung Hang Chow, et al.. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.. PubMed. 276(24). 1957–63. 605 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact